A systematic review and meta-analysis of placebo versus no treatment for insomnia symptoms

Sleep Medicine Reviews

Volumn 38, Issue , 2018, Pages 17-27

  Yeung, Valerie ^a   Sharpe, Louise ^a   Glozier, Nick ^b   Hackett, Maree L ^a,c   Colagiuri, Ben ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

Author keywords

Expectancy; Insomnia; Placebo effect; Placebo response; Sleep

Indexed keywords

HUMAN; INSOMNIA; OUTCOME ASSESSMENT; PLACEBO EFFECT; REVIEW; SELF REPORT; SLEEP INDUCTION; SLEEP LATENCY; SLEEP QUALITY; SLEEP TIME; SYMPTOM; SYSTEMATIC REVIEW; DRUG EFFECT; PHYSIOLOGY; SLEEP;

HUMANS; PLACEBO EFFECT; SELF REPORT; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 85019683121     PISSN: 10870792     EISSN: 15322955     Source Type: Journal    
DOI: 10.1016/j.smrv.2017.03.006     Document Type: Review

References (62)

1. Bélanger, L., Vallières, A., Ivers, H., Moreau, V., Lavigne, G., Morin, C.M., Meta-analysis of sleep changes in control groups of insomnia treatment trials. J Sleep Res 16 (2007), 77–84.
2. McCall, W.V., D'Agostino, R., Dunn, A., A meta-analysis of sleep changes associated with placebo in hypnotic clinical trials. Sleep Med 4 (2003), 57–62.
3. Winkler, A., Rief, W., Effect of placebo conditions on polysomnographic parameters in primary insomnia: a meta-analysis. Sleep, 38, 2015 925-U232.
4. Huedo-Medina, T.B., Kirsch, I., Middlemass, J., Klonizakis, M., Siriwardena, A.N., Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration. Br Med J, 345, 2012.
5. Kirsch, I., The placebo effect revisited: lessons learned to date. Complement Ther Med 21 (2013), 102–104.
6. Lund, K., Vase, L., Petersen, G.L., Jensen, T.S., Finnerup, N.B., Randomised controlled trials may underestimate drug effects: balanced placebo trial design. PLoS One, 9, 2014, e84104.
7. Rutherford, B.R., Roose, S.P., A model of placebo response in antidepressant clinical trials. Am J Psychiatry 170 (2013), 723–733.
8. Ernst, E., Resch, K.L., Concept of true and perceived placebo effects. Br Med J 311 (1995), 551–553.
9. Kienle, G.S., Kiene, H., The powerful placebo effect: fact or fiction?. J Clin Epidemiol 50 (1997), 1311–1318.
10. McCarney, R., Warner, J., Iliffe, S., Van Haselen, R., Griffin, M., Fisher, P., The Hawthorne effect: a randomised, controlled trial. BMC Med Res Methodol, 7, 2007, 1.
11. Barnett, A.G., van der Pols, J.C., Dobson, A.J., Regression to the mean: what it is and how to deal with it. Int J Epidemiol 34 (2005), 215–220.
12. McCall, W.V., D'Agostino, R., Rosenquist, P.B., Kimball, J., Boggs, N., Lasater, B., et al. Dissection of the factors driving the placebo effect in hypnotic treatment of depressed insomniacs. Sleep Med 12 (2011), 557–564.
13. Perlis, M.L., McCall, W.V., Jungquist, C.R., Pigeon, W.R., Matteson, S.E., Placebo effects in primary insomnia. Sleep Med Rev 9 (2005), 381–389.
14. Colagiuri, B., Participant expectancies in double-blind randomized placebo-controlled trials: potential limitations to trial validity. Clin Trials 7 (2010), 246–355.
15. Hróbjartsson, A., Gøtzsche, P.C., Placebo interventions for all clinical conditions. Cochrane Database Syst Rev, 1, 2010 article number: CD003974.
16. Kirsch, I., Weixel, L.J., Double-blind versus deceptive administration of a placebo. Behav Neurosci 102 (1988), 319–323.
17. Pollo, A., Torre, E., Lopiano, L., Rizzone, M., Lanotte, M., Cavanna, A., et al. Expectation modulates the response to subthalamic nucleus stimulation in Parkinsonian patients. Neuroreport 13 (2002), 1383–1386.
18. Vase, L., Riley, J.L., Price, D.D., A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia. Pain 99 (2002), 443–452.
19. Morin, C.M., Benca, R., Chronic insomnia. The Lancet 379 (2012), 1129–1141.
20. Buysse, D.J., Reynolds, C.F., Monk, T.H., Berman, S.R., Kupfer, D.J., The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28 (1989), 193–213.
21. Bastien, C.H., Vallieres, A., Morin, C.M., Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med 2 (2001), 297–307.
22. Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151 (2009), 264–269.
23. Borenstein, M., Hedges, L.V., Higgins, J.P.T., Rothstein, H.R., Comprehensive meta-analysis. 2nd ed., 2005, Biostat, Englewood NJ.
24. Hedges, L.V., Distribution theory for Glass's estimator of effect size and related estimators. J Educ Behav Stat 6 (1981), 107–128.
25. Cohen, J., Statistical power analysis for the behavioural sciences. 2nd ed., 1988, Lawrence Earlbaum Associates, Hillsdale, NJ.
26. Higgins, J.P.T., Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-analyses. Br Med J 327 (2003), 557–560.
27. Greenland, S., Invited commentary: a critical look at some popular meta-analytic methods. Am J Epidemiol 140 (1994), 290–296.
28. Greenland, S., Quality scores are useless and potentially misleading: reply to “Re: A critical look at some popular analytic methods”. Am J Epidemiol 140 (1994), 300–301.
29. Emerson, J.D., Burdick, E., Hoaglin, D.C., Mosteller, F., Chalmers, T.C., An empirical study of the possible relation of treatment differences to quality scores in controlled randomized clinical trials. Control Clin Trials 11 (1990), 339–352.
30. Jüni, P., Witschi, A., Bloch, R., Egger, M., The hazards of scoring the quality of clinical trials for meta-analysis. J Am Med Assoc 282 (1999), 1054–1060.
31. Higgins, J.P.T., Altman, D.G., Gøtzsche, P.C., Jüni, P., Moher, D., Oxman, A.D., et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. Br Med J, 343, 2011, d5928.
32. Ioannidis, J.P.A., Trikalinos, T.A., The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey. Can Med Assoc J 176 (2007), 1091–1096.
33. Egger, M., Smith, G.D., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test. Br Med J 315 (1997), 629–634.
34. Duval, S., Tweedie, R., Trim and fill: a simple funnel-plot–based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56 (2000), 455–463.
35. Borenstein, M., Hedges, L.V., Higgins, J.P.T., Rothstein, H.R., A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods 1 (2010), 97–111.
36. Geers, A.L., Weiland, P.E., Kosbab, K., Landry, J., Helfer, S.G., Goal activation, expectations, and the placebo effect. J Pers Soc Psychol 89 (2005), 143–159.
37. McCall, W.V., Perlis, M.L., Tu, X., Groman, A.E., Krystal, A., Walsh, J.K., A comparison of placebo and no-treatment during a hypnotic clinical trial. Int J Clin Pharmacol Ther 43 (2005), 355–359.
38. Nicassio, P., Bootzin, R., Comparison of progressive relaxation and autogenic training as treatments for insomnia. J Abnorm Psychol 83 (1974), 253–260.
39. Steinmark, S.W., Borkovec, T.D., Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. J Abnorm Psychol 83 (1974), 157–163.
40. Borkovec, T.D., Weerts, T.C., Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosom Med 38 (1976), 173–180.
41. Lick, J.R., Heffler, D., Relaxation training and attention placebo in the treatment of severe insomnia. J Consult Clin Psychol 45 (1977), 153–161.
42. Turner, R.M., Ascher, L.M., Controlled comparison of progressive relaxation, stimulus-control, and paradoxical intention therapies for insomnia. J Consult Clin Psychol 47 (1979), 500–508.
43. Espie, C.A., Lindsay, W.R., Brooks, D.N., Hood, E.M., Turvey, T., A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behav Res Ther 27 (1989), 79–88.
44. Colagiuri, B., McGuinness, K., Boakes, R.A., Butow, P.N., Warning about side effects can increase their occurrence: an experimental model using placebo treatment for sleep difficulty. J Psychopharmacol, 2012, 1540–1547.
45. Neukirch, N., Colagiuri, B., The placebo effect, sleep difficulty, and side effects: a balanced placebo model. J Behav Med 38 (2015), 273–283.
46. Bootzin, R.R., Herman, C.P., Nicassio, P., The power of suggestion: another examination of misattribution and insomnia. J Pers Soc Psychol 34 (1976), 673–679.
47. Borkovec, T.D., Kaloupek, D.G., Slama, K.M., Facilitative effect of muscle tension-release in relaxation treatment of sleep disturbance. Behav Ther 6 (1975), 301–309.
48. Walsh, J.K., Roth, T., Randazzo, A., Erman, M., Jamieson, A., Scharf, M., et al. Eight weeks of non-nightly use of zolpidem for primary insomnia. Sleep 23 (2000), 1087–1096.
49. Fratello, F., Curcio, G., Ferrara, M., Marzano, C., Couyoumdjian, A., Petrillo, G., et al. Can an inert sleeping pill affect sleep? Effects on polysomnographic, behavioral and subjective measures. Psychopharmacology (Berl) 181 (2005), 761–770.
50. Espie, C.A., Kyle, S.D., Williams, C., Ong, J.C., Douglas, N.J., Hames, P., et al. A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep 35 (2012), 769–781.
51. Tuttle, A.H., Tohyama, S., Ramsay, T., Kimmelman, J., Schweinhardt, P., Bennett, G.J., et al. Increasing placebo responses over time in US clinical trials of neuropathic pain. Pain 156 (2015), 2616–2626.
52. Walsh, B.T., Seidman, S.N., Sysko, R., Gould, M., Placebo response in studies of major depression: variable, substantial, and growing. J Am Med Assoc 287 (2002), 1840–1847.
53. de Craen, A.J.M., Moerman, D.E., Heisterkamp, S.H., Tytgat, G.N.J., Tijssen, J.G.P., Kleijnen, J., Placebo effect in the treatment of duodenal ulcer. Br J Clin Pharmacol 48 (1999), 853–860.
54. de Craen, A.J.M., Tijssen, J.G.P., de Gans, J., Kleijnen, J., Placebo effect in the acute treatment of migraine: subcutaneous placebos are better than oral placebos. J Neurol 247 (2000), 183–188.
55. Okajima, I., Komada, Y., Inoue, Y., A meta-analysis on the treatment effectiveness of cognitive behavioural therapy for primary insomnia. Sleep Biol Rhythms 9 (2011), 24–34.
56. Lambert, M.J., Early response in psychotherapy: further evidence for the importance of common factors rather than “placebo effects”. J Clin Psychol 61 (2005), 855–869.
57. Wampold, B.E., How important are the common factors in psychotherapy? An update. World Psychiatry 14 (2015), 270–277.
58. American Psychiatric Association, Diagnostic and statistical manual of mental disorders. 4th ed., 2000, American Psychiatric Association, Washington, DC.
59. Morin, C.M., Measuring outcomes in randomized clinical trials of insomnia treatments. Sleep Med Rev 7 (2003), 263–279.
60. Schutte-Rodin, S., Broch, L., Buysse, D., Dorsey, C., Sateia, M., Clinical guidelines for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 4 (2008), 487–504.
61. Draganich, C., Erdal, K., Placebo sleep affects cognitive functioning. J Exp Psychol Learn Mem Cogn, 40, 2014, 857.
62. Vgontzas, A.N., Fernandez-Mendoza, J., Liao, D., Bixler, E.O., Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder. Sleep Med Rev 17 (2013), 241–254.